Fatty acid-binding protein 3 (Fabp3) is an intracellular lipid trafficking protein that mediates energy metabolism and long-chain fatty acid-related signaling. Fabp3 is expressed in the spiral ganglion neurons and supporting cells of the organ of Corti. However, it is unclear what role Fabp3 plays in the cochlea. Here, we demonstrated that the ABR thresholds of young and aged Fabp3 knockout mice were unchanged compared with those of wild-type mice. Compared with the wild-type mice, the adult mutant mice demonstrated no differences in their vulnerability to acoustic overexposure. These results suggest that Fabp3 deficiency alone does not adversely affect hearing function.
Rapid communication
Fatty acid-binding proteins (Fabps) are intracellular lipid trafficking proteins that bind to fatty acids (FAs) and other lipophilic substances and regulate metabolic pathways. Fabps also modulate gene expressions (Furuhashi and Hotamisligil, 2008; Owada, 2008; Storch and Thumser, 2010) . The Fabp family has at least 10 members in mammals (Liu et al., 2008) ; two members, Fabp3 (heart-type, H-Fabp) and Fabp7 (brain-type, B-Fabp), have been identified in the mouse cochlea (Saino-Saito et al., 2010) .
Fabp3 is required for long-chain FA transport to maintain efficient mitochondrial beta-oxidation, and it interacts with the nuclear receptors (e.g., PPAR-alpha) in the heart (Tan et al., 2002; Storch and Thumser, 2010) . Fabp3 knockout (KO) mice exhibit major alterations in peripheral free long-chain FA utilization, acute exercise intolerance in young age groups, and cardiac hypertrophy in old age groups (Binas et al., 1999) . Fabp3 is also expressed in the adult brain, and it is necessary to maintain the n-6/n-3-polyunsaturated fatty acid (PUFA) balance, particularly for arachidonic acid (ARA) uptake and metabolism in neurons * Corresponding author. Tel.: +81 022 717 8203; fax: +81 022 717 8205.
E-mail addresses: norikoosumi1128@gmail.com, osumi@med.tohoku.ac.jp (N. Osumi). (Murphy et al., 2005; Storch and Thumser, 2010 ). An imbalance in the n-6/n-3-PUFA ratio may be a pathological factor in several neuropsychiatric disorders (Sakayori and Osumi, 2013) . FABP3 levels are decreased in the brains of patients with Down syndrome and Alzheimer's disease (Cheon et al., 2003) , which provides indirect evidence of a relationship between FABP3 and neurological functions and diseases (Storch and Thumser, 2010) . These studies indicate that Fabp3 may have an important role in maintaining normal brain functions.
The cochlea is a main pathological region for sensorineural hearing loss (e.g., age-related hearing loss [AHL] and noise-induced hearing loss [NIHL] ) (Ohlemiller, 2008; Kidd Iii and Bao, 2012) . There are no effective treatments for sensorineural hearing loss; therefore, it is important to recognize the molecular mechanisms at work in the cochlea. Fabp3 is expressed in supporting cells (e.g., the inner and outer pillar cells and outer phalangeal cells) in the organ of Corti (OC) and spiral ganglion (SG) neurons (Saino-Saito et al., 2010) , which suggests its role in regulating the hearing function. However, no studies of the Fabp3 function in the cochlea have been reported. Fabp3 is involved in apoptosis (Zhu et al., 2011; Song et al., 2012) , which is critical in various pathophysiological processes. Apoptosis is also critical for AHL (Yamasoba et al., 2013) and NIHL (Op de Beeck et al., 2011) . Therefore, we evaluated the cochlear function of Fabp3 KO mice and focused on AHL and NIHL. Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license. We used Fabp3 KO (Fabp3(−/−)) (Binas et al., 1999) and wildtype (Fabp3(+/+)) mice with a C57BL/6 genetic background. The following primers were used for genotyping: Fabp3 wild-type forward 5 -agc cga gtg gac agg ctc aag g-3 , Fabp3 KO forward 5 -taa agc gca tgc tcc aga ctg cc-3 , and Fabp3 common reverse 5 -caa ggc cac cag cag gtc aca g-3 . The Ethics Committee for Animal Experiments of Tohoku University Graduate School of Medicine approved all experimental procedures (no. 2011-231) .
We confirmed the Fabp3 expression patterns in the cochlea of female wild-type mice (age 3-4 months). The mice were anesthetized using diethyl ether and perfused with 0.01 M phosphate-buffered saline (PBS) and 4% paraformaldehyde (PFA) in PBS (pH 7.4). The inner ears were post-fixed with 4% PFA at 4 • C overnight, decalcified in 10% ethylenediaminetetraacetic acid (EDTA) for 2 days at 4 • C, sequentially treated in 10% and 30% sucrose, embedded in Tissue-Tek O.T.C. Compound (Sakura Finetechnical), and frozen on dry ice. Thin sections (10 m) were cut using a cryostat (CM3050, Leica Instruments). Immunohistochemistry was performed with modification (Suzuki et al., 2013) according to a previously described procedure. Briefly, tissue sections were rinsed in 0.1% Triton X-100/Tris buffered saline (TBS), blocked with 3% bovine serum albumin/0.3% Triton X-100/TBS for 30 min at room temperature, and incubated with an unconjugated AffiniPure Fab fragment Anti-Mouse IgG (1:10, Jackson ImmunoResearch) for 2 h at room temperature. The primary and secondary antibodies are listed in Table 1A . The sections were incubated overnight with primary antibodies at 4 • C followed by the appropriate secondary antibodies for 1 hr at room temperature. The samples were visualized enzymatically using the avidin-biotin complex (VECTASTAIN Elite ABC Kit, Vector Labs) and 3,3 -diaminobenzidine (DAB). The nuclei were counterstained with 4 ,6-diamidino-2-phenylindole (DAPI) (1:2000) using fluorescent immunochemistry. Fluorescence images and light images were obtained using a microscope (BZ-9000, Keyence) and BZ-H1C software (Keyence) or a laser-scanning confocal microscope (LSM 510-Meta, Zeiss) and LSM Image Browser (Zeiss).
Next, we investigated the Fabp7 mRNA expression in the cochleae of Fabp3 KO mice using quantitative real-time polymerase chain reaction (qRT-PCR). Male Fabp3(+/+) and Fabp3(−/−) mice were sacrificed at 2 months of age, and their cochleae were dissected. Using an RNA isolation reagent (TRIzol, Life Technologies), total RNA was isolated from 2 cochleae for each sample. cDNA was synthesized using the SuperScript III First-Strand Synthesis System (Invitrogen). Measurements were obtained using PCR thermal cyclers (Mastercycler ep realplex, Eppendorf) and a FastStart SYBR Green Master (Roche). The following cycling conditions were used: 94 • C for 10 min, 45 cycles of 94 • C for 10 s, 60 • C for 5 s, and 72 • C for 10 s. The samples were run in duplicate, and the gene expression levels were determined using the Pfaffl method (Pfaffl, 2001 ) with TATA box-binding protein (TBP) as (E and F) ABR hearing thresholds in male Fabp3(+/+) and Fabp3(−/−) mice before acoustic overexposure (E) and 7 days after exposure to octave band noise (4-8 kHz) for 2 h at 103 dB SPL (F). Fabp3 deletion does not affect vulnerability to severe acoustic injury. Data are expressed as the mean ± the standard error of the mean (SEM). Statistical analysis was performed using the two-sample t-test, and p < 0.05 was considered to be statistically significant.
an internal standard. Signal fold-changes were determined using normalized data from Fabp3(+/+) mice as the controls. The primers used in this study are listed in Table 1B. Fabp3 immunoreactivity was detected equally within the supporting cells in the OC (Fig. 1A and A ) and SG neurons (Fig. 1B and B ) in every turn of the cochlea. Background signals, especially in the bone, were apparent despite Fab blocking (Fig. 1B and B ) . In contrast, Fabp7 was observed in fibrocytes in the spiral limbus (SLim), supporting cells in the OC (Fig. 1A and A ) , satellite cells in the SG (Fig. 1B and B ) , and fibrocytes the spiral ligament (SLig, data not shown). We performed multiple immunostaining techniques using anti-Fabp3, anti-Sox2 (a marker for supporting cells), and anti-Myosin 7a (Myo7a, a marker for hair cells) antibodies to observe the detailed expression patterns of Fabp3 in the OC. Fabp3 expression was strongly observed in the nucleus and weakly observed in the cytoplasm of the Sox2-positive and Myo7a-negative supporting cells (Fig. 1C and C ) . The positional relationship between Fabp3-positive cells and Myo7a-positive hair cells determined that Deiters cells (DCs) and inner and outer pillar cells (PCs) expressed Fabp3. We also investigated the absence of Fabp3 localization in the cochleae of Fabp3(−/−) mice. Background signals remained strong in the bone, but Fabp3 immunoreactivity was undetectable in SG neurons ( Fig. 2B and E) and supporting cells in the OC (Fig. 2C and F) . qRT-PCR analysis revealed that Fabp3 mRNA expression was undetectable in the Fabp3(−/−) mice, and Fabp7 mRNA expression was similar in the Fabp3(+/+) and Fabp3(−/−) mice (Fig. 2G) . These results confirmed the specific expression of Fabp3 in mouse cochlea, as previously reported (Saino-Saito et al., 2010) , and indicated that the Fabp3(−/−) mice lack Fabp3 mRNA and protein expression in the cochlea. No compensatory up-regulation of Fabp7 mRNA was observed in the cochleae of the Fabp3(−/−) mice.
The C57BL/6 strain exhibits an early progression of AHL (Zheng et al., 1999) . The effects of Fabp3 deficiency on AHL progression were investigated by measuring ABR. The mice were anesthetized usingintraperitoneal ketamine (100 mg/kg) and xylazine (20 mg/kg). ABR recordings were performed using a TDT System 3 auditory-evoked potential workstation and BioSigRP software (Tucker-Davis Technologies). ABR responses were evoked using tone bursts of pure tones at frequencies of 4, 8, 12, 16, and 32 kHz.
Evoked responses were averaged across 500 sweeps. Responses were collected for stimulus levels in 5-dB steps from 100 dB SPL (sound pressure level) to 10 dB SPL. The ABR threshold was defined as the lowest stimulus level required to produce a visual detection of at least one ABR wave.
We measured the ABR thresholds of female Fabp3(+/+) and Fabp3(−/−) mice at 2 and 12 months of age ( Fig. 3A and B) . ABR thresholds of Fabp3(+/+) and Fabp3(−/−) mice showed no significant differences at 2 months (Fig. 3A) and 12 months of age (Fig. 3B) . Representative results from the ABR waves at 12 kHz in the 12-month-old mice are shown in Fig. 3C . Fabp3 deficiency did not affect the AHL progression, contrary to our expectations.
Finally, we performed acoustic overexposure to induce a permanent threshold shift (PTS) (Yoshida et al., 1999) . At 2 months of age, male Fabp3(+/+) and Fabp3(−/−) mice were exposed to an octave of band noise (4-8 kHz) at 103 dB SPL for 2 h. A summary of the experiments is shown in Fig. 3D . The baseline ABR thresholds were not different between the Fabp3(+/+) and Fabp3(−/−) mice (Fig. 3E ). PTSs were measured 7 days after the acoustic overexposure, and no significant differences were observed between the Fabp3(+/+) and Fabp3(−/−) mice (Fig. 3F ). Fabp3 deficiency did not impact the noise-induced PTS.
This study demonstrated that ABR thresholds in young and old mice were unaltered in Fabp3(−/−) mice compared with Fabp3(+/+) mice. We cannot exclude the possibility that the onset time of AHL may be different; however, our results suggest that Fabp3(−/−) mice have normal sensory and neural functions in the cochlea. Fabp3(−/−) mice showed no significant vulnerability to the acoustic overexposure that causes PTS. Therefore, Fabp3 is specifically expressed in SG neurons, DCs, and inner and outer PCs (i.e., the major cell types in hearing function), but its deficiency alone does not affect cochlear function or the protective mechanisms of severe acoustic overexposure.
The absence of auditory dysfunction in Fabp3 KO mice may be caused by the compensatory up-regulation of other Fabps in the cochlea, which is similar to the dramatically increased expression of Fabp5 in the adipocytes of Fabp4-deficient mice (Hotamisligil et al., 1996) . The expression of the selected Fabps (e.g., Fabps1-5 and Fabp7) was examined in wild-type cochlea (Saino-Saito et al., 2010) . Other Fabps may co-localize in Fabp3-expressing cells and compensate for the lack of Fabp3. Further investigation of the other Fabps in the cochlea is needed.
Fabp3 interacts with dopamine D2 receptor (D2R) in cholinergic interneurons and glutamatergic terminals in the dorsal striatum of the brain, and Fabp3 KO mice exhibit D2R dysfunction and aberrant activation of cholinergic and glutamatergic neurotransmission (Shioda et al., 2010) . D2Rs in the cochlea are localized in cochlear nerve fibers and the inner spiral bundle region, and the vulnerability to acoustic injury that causes a temporary threshold shift (TTS) increases in mice that lack D2Rs (Maison et al., 2012) . This study used a PTS model to observe the effect of Fabp3 deficiency. We found that the specific expression of Fabp3 in cochlear neurons exhibited a less than expected impact on the vulnerability to the severe acoustic overexposure that induces the apoptosis of cochlear cells. However, Fabp3(−/−) mice may be vulnerable to mild acoustic overexposure. Future studies should investigate how D2R dysfunction impacts the cochlea and how it alters the vulnerability to mild acoustic overexposure in Fabp3(−/−) mice.
In conclusion, Fabp3 KO mice exhibited no auditory phenotypes after aging or acoustic overexposure. Interestingly, a preliminary delay of AHL progression was observed in mice lacking Fabp7 which was specifically expressed in the glia and supporting cells in the cochlea but not in the SG neurons or hair cells (Suzuki et al., unpublished) . Therefore, evaluations of Fabp7 function in the cochlea would aid in the elucidation of AHL pathophysiology.
